Stryker Corporation
SYK
Ранг среди акций
#191
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Цена акции
$304.72
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$116.88B
Изменение (1 день)
1.96%
Изменение (1 год)
-19.76%
Страна
US
Торговля Stryker Corporation (SYK)
Категория
Healthcare
Коэффициент P/E для Stryker Corporation (SYK)
Коэффициент P/E на October 2026 TTM: 28.94
Согласно последним финансовым отчетам и цене акций Stryker Corporation, текущий P/E (TTM) составляет 28.94. В конце 2024 у компании был P/E на уровне 45.83.
История P/E компании Stryker Corporation с 2000 по 2026
P/E на конец каждого года
| Год | P/E коэффициент | Изменить |
|---|---|---|
| 2026 (TTM) | 28.94 | -30.05% |
| 2025 | 41.38 | -9.71% |
| 2024 | 45.83 | 27.61% |
| 2023 | 35.92 | -8.41% |
| 2022 | 39.21 | -22.44% |
| 2021 | 50.56 | -12.14% |
| 2020 | 57.54 | 52.66% |
| 2019 | 37.69 | 128.39% |
| 2018 | 16.50 | -70.93% |
| 2017 | 56.77 | 108.63% |
| 2016 | 27.21 | 11.88% |
| 2015 | 24.32 | -64.92% |
| 2014 | 69.33 | 145.16% |
| 2013 | 28.28 | 75.92% |
| 2012 | 16.07 | 12.53% |
| 2011 | 14.28 | -14.55% |
| 2010 | 16.72 | -7.52% |
| 2009 | 18.08 | 27.26% |
| 2008 | 14.20 | -52.79% |
| 2007 | 30.09 | 4.28% |
| 2006 | 28.85 | 8.62% |
| 2005 | 26.56 | -36.09% |
| 2004 | 41.57 | 6.61% |
| 2003 | 38.99 | -3.57% |
| 2002 | 40.43 | -4.42% |
| 2001 | 42.30 | -5.53% |
| 2000 | 44.78 | 0.00% |
P/E для схожих компаний или конкурентов
| Компания | P/E Ratio | Разница P/E | Страна |
|---|---|---|---|
| 33.11 | 14.39% |
US
|
|
| 21.39 | -26.11% |
IE
|
|
| 17.34 | -40.10% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 71.65% |
US
|
Как читать P/E Ratio?
Коэффициент цена/прибыль (P/E Ratio) отражает соотношение между ценой акции компании и её прибылью на акцию.
Низкий, но положительный P/E говорит о том, что компания приносит высокую прибыль при низкой оценке и может быть недооценена. Высокий отрицательный (близкий к 0) P/E указывает на значительные убытки.
Компании с P/E выше 30 или отрицательным считаются "акциями роста" — инвесторы ожидают роста или будущей прибыли.
Компании с положительным P/E ниже 10 считаются "ценностными акциями", т.е. уже прибыльны, но с низким потенциалом роста.